Medicine
- Tue. 11/10
FDA adds warning about a rare, sudden vision loss to Ozempic, Wegovy, Zepbound and all other GLP-1 drugs
The risk is small and the FDA has not proven the drugs cause it. Anyone who suddenly loses vision in one eye should call a doctor right away.
- Tue. 11/10
UCSF trial: A kudzu plant extract taken before drinking cut binge-drinking days, but store-bought supplements may not work the same
The benefit lasted three months after people stopped taking it. Researchers say larger studies are needed.
- Tue. 11/10
After a stroke, a lower blood pressure goal cut repeat heart attacks and strokes by about a fifth, a large trial finds
A second, smaller study found that adding a cheap, decades-old ‘water pill’ helped twice as many survivors reach their blood pressure goal.
- Tue. 11/10
Lilly’s weight-loss pill Foundayo cut sleep apnea breathing pauses in two yearlong trials; FDA filing planned by year’s end
The pill is approved in the U.S. for obesity but not yet for sleep apnea. Stomach side effects were common.
- Mon. 11/09
One-time gene-editing infusion cut dangerous blood fats by 63% in a small early trial
CRISPR Therapeutics, which does research in San Francisco, says its CTX310 switches off a fat-raising gene in the liver. Only 10 patients were treated, and long-term effects are unknown.
- Fri. 11/06
NIH lab study finds 13 antibodies that target molecules linked to tick-related red-meat allergy
No specific alpha-gal treatment exists today beyond managing reactions. Lab antibodies are an early research step, not a proven human therapy. Talk with a doctor about symptoms.
- Mon. 11/02
Winter wood-burning bans are back, and they will be called more often
From November through February, burning wood is illegal on Spare the Air days. A tighter rule means more alert days than in past winters.
